Inventor · disambiguated record
William Stirtan
Also filed as: STIRTAN WILLIAM · STIRTAN WILLIAM G
3 granted patents·15 pending applications·43 citations·filing 1998–2023
70Inventor score
Top patents by PatentIndex Score
18 records- 0191US10966968B2Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Apr 6, 2021·9 cites·4 claims
- 0286US6242461B1Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseasesPFIZER·Filed 2000·Granted Jun 5, 2001·31 cites·9 claims
- 0375US2023310372A1Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2023·Application pending·0 cites
- 0472US2022323395A1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2022·Application pending·0 cites
- 0571US2019183840A1Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Application pending·0 cites
- 0669US2014249220A1Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 0768US2021069145A1Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 0866US2014249200A1Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 0965US2014357717A1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 1064US2020108041A1Methods of reducing ldl-pAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Application pending·0 cites
- 1164US2017143657A1Compositions and methods for reducing a fatty acid desaturation index in a subject in need thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Application pending·0 cites
- 1263US2020268702A1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Application pending·0 cites
- 1362US2018015071A1Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereofAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Application pending·0 cites
- 1459US2015157593A1Methods of reducing ldl-pAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Application pending·0 cites
- 1552US2014221676A1Compositions and methods for treating and/or preventing cardiovascular diseaseAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 1652US2014249214A1Co-administration of warfarin and ethyl eicosapentaenoateAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Application pending·0 cites
- 1750US2014004183A1Methods for treating cardiovascular disease in statin-tolerant subjectsAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Application pending·0 cites
- 1834US5981762ASubstituted indole-2-carboxylic acids as glucosyl transferase inhibitorsPFIZER·Filed 1998·Granted Nov 9, 1999·3 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when William Stirtan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →